| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8453488 | Leukemia Research | 2016 | 7 Pages |
Abstract
Taken together, these data indicate that EZH2 underexpression may have unique impact on the molecular pathogenesis and prognosis in MDS and be an important marker for patients without chromosome 7 alteration.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Monica Cabrero, Yue Wei, Hui Yang, Irene Ganan-Gomez, Zach Bohannan, Simona Colla, Matteo Marchesini, Guillermo Montalban Bravo, Koichi Takahashi, Carlos Bueso-Ramos, Guillermo Garcia-Manero,